-
Mashup Score: 0ESMO WCGIC 2022 Archives | VJOncology - 1 year(s) ago
ESMO World Congress On Gastrointestinal Cancer 2022 29 Jun–02 July 2022 | Barcelona, Spain, and Online The ESMO World Congress on Gastrointestinal Cancer represents the year’s premier gathering of international oncology professionals who are dedicated to improving the lives of patients impacted by malignancies of the GI tract. ESMO World Congress On Gastrointestinal Cancer 2022 29…
Source: VJOncologyCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 2Targeted therapies for cholangiocarcinoma - 2 year(s) ago
Approximately 40% of patients with cholangiocarcinoma have genetic alterations for which targeted therapies already exist. Arndt Vogel, MD, PhD, Hannover…
Source: VJOncologyCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0Treatments for HER2+ esophagogastric cancer - 2 year(s) ago
Per Pfeiffer, MD, PhD, Odense University Hospital and University of Southern Denmark, Odense, Denmark, discusses recent research into treatments for…
Source: VJOncologyCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0
Julien Taieb, MD, PhD, European Hospital Georges Pompidou, Paris, France, discusses the importance of identifying which patients with colon cancer…
Source: VJOncologyCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0Standard-of-care for adjuvant treatment of colon cancer - 2 year(s) ago
Julien Taieb, MD, PhD, European Hospital Georges Pompidou, Paris, France, explains the current standard of care for adjuvant treatment of…
Source: VJOncologyCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0TAS-102 plus bevacizumab vs. TAS-102 alone for previously treated metastatic esophagogastric cancer - 2 year(s) ago
Per Pfeiffer, MD, PhD, Odense University Hospital and University of Southern Denmark, Odense, Denmark, discusses an investigator-initiated randomised study that…
Source: VJOncologyCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0DELIVER trial: Blood based biomarker analysis of patients with gastric cancer treated with nivolumab - 2 year(s) ago
Hisato Kawakami, MD, PhD, Kindai University, Osaka, Japan, discusses results from a blood-based biomarker analysis of the DELIVER trial which…
Source: VJOncologyCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0Promising future for cholangiocarcinoma diagnosis and treatment - 2 year(s) ago
Lorenza Rimassa, MD, Humanitas University and IRCCS Humanitas Research Hospital, Milan, Italy, discusses recent positive trials of immunotherapy plus chemotherapy…
Source: VJOncologyCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0Targeted therapies for patients with HER2+ colorectal cancer - 2 year(s) ago
Jonathan Strickler, MD, Duke Cancer Institute, Durham, NC, discusses the key points from his talk at ESMO WCGIC 2022 on…
Source: VJOncologyCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0Therapeutic challenges for cholangiocarcinoma - 2 year(s) ago
Lorenza Rimassa, MD, Humanitas University and IRCCS Humanitas Research Hospital, Milan, Italy, discusses the therapeutic challenges for patients with cholangiocarcinoma….
Source: VJOncologyCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
🚨It's #LiverCancerAwarenessMonth! Why not check out some of the latest updates in liver cancer from #WCGIC22? Watch here: 💻 https://t.co/kw8ScFNFse @myESMO @ESMOWorldGI https://t.co/BECfDVJijz